These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19855356)

  • 41. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice.
    Peters S; Slattery DA; Uschold-Schmidt N; Reber SO; Neumann ID
    Psychoneuroendocrinology; 2014 Apr; 42():225-36. PubMed ID: 24636519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of grooming behavior potencies of neurohypophyseal nonapeptides.
    Caldwell JD; Drago F; Prange AJ; Pedersen CA
    Regul Pept; 1986 May; 14(3):261-71. PubMed ID: 3014615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test.
    Chaviaras S; Mak P; Ralph D; Krishnan L; Broadbear JH
    Psychopharmacology (Berl); 2010 May; 210(1):35-43. PubMed ID: 20232054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxytocin and cholecystokinin induce grooming behavior in the ventral tegmentum of the rat.
    Kaltwasser MT; Crawley JN
    Brain Res; 1987 Nov; 426(1):1-7. PubMed ID: 3690307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RGS2 mediates the anxiolytic effect of oxytocin.
    Okimoto N; Bosch OJ; Slattery DA; Pflaum K; Matsushita H; Wei FY; Ohmori M; Nishiki T; Ohmori I; Hiramatsu Y; Matsui H; Neumann ID; Tomizawa K
    Brain Res; 2012 May; 1453():26-33. PubMed ID: 22459044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury.
    Meidahl AC; Eisenried A; Klukinov M; Cao L; Tzabazis AZ; Yeomans DC
    Headache; 2018 Apr; 58(4):545-558. PubMed ID: 29266199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic efficiency of Atosiban, an oxytocin receptor blocking agent in the treatment of experimental endometriosis.
    Simsek Y; Celik O; Karaer A; Gul M; Yılmaz E; Koc O; Colak C; Zengin S; Aydin NE
    Arch Gynecol Obstet; 2012 Sep; 286(3):777-83. PubMed ID: 22648446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxytocin potently enhances novelty-induced grooming behavior in the rat.
    Drago F; Pedersen CA; Caldwell JD; Prange AJ
    Brain Res; 1986 Mar; 368(2):287-95. PubMed ID: 3697728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurotransmitter-mediated open-field behavioral action of CGRP.
    Kovács A; Telegdy G; Tóth G; Penke B
    Life Sci; 1999; 64(9):733-40. PubMed ID: 10075105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxytocin reversed MK-801-induced social interaction and aggression deficits in zebrafish.
    Zimmermann FF; Gaspary KV; Siebel AM; Bonan CD
    Behav Brain Res; 2016 Sep; 311():368-374. PubMed ID: 27247142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Phoenixin-14 on anxiolytic-like behavior in mice.
    Jiang JH; He Z; Peng YL; Jin WD; Mu J; Xue HX; Wang Z; Chang M; Wang R
    Behav Brain Res; 2015 Jun; 286():39-48. PubMed ID: 25687846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central nervous system actions of oxytocin and modulation of behavior in humans.
    McCarthy MM; Altemus M
    Mol Med Today; 1997 Jun; 3(6):269-75. PubMed ID: 9211418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban.
    Bartekova M; Barancik M; Pokusa M; Prokopova B; Radosinska J; Rusnak A; Breier A; Jezova D
    Can J Physiol Pharmacol; 2015 Sep; 93(9):827-34. PubMed ID: 26323039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological investigations on adaptation in rats subjected to cold water immersion stress.
    Agrawal A; Jaggi AS; Singh N
    Physiol Behav; 2011 Jun; 103(3-4):321-9. PubMed ID: 21324329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxytocin microinjected into the central amygdaloid nuclei exerts anti-aggressive effects in male rats.
    Calcagnoli F; Stubbendorff C; Meyer N; de Boer SF; Althaus M; Koolhaas JM
    Neuropharmacology; 2015 Mar; 90():74-81. PubMed ID: 25437825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The block of central vasopressin V1 but not V2 receptors suppresses grooming behavior and hypothermia induced by intracerebroventricular vasopressin in male rats.
    Drago F; Stanciu M; Salehi S; Scapagnini U
    Peptides; 1997; 18(9):1389-92. PubMed ID: 9392841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes of open field behavior in animal model of depression.
    Chkhartishvili E; Maglakelidze N; Babilodze M; Chijavadze E; Nachkebia N
    Georgian Med News; 2011 Nov; 11(200):107-12. PubMed ID: 22201090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks.
    Micale V; Scapagnini G; Colombrita C; Mazzola C; Alkon DL; Drago F
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):462-71. PubMed ID: 18222653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal administration of oxytocin increases novelty-induced grooming in the adult rat.
    Noonan LR; Continella G; Pedersen CA
    Pharmacol Biochem Behav; 1989 Jul; 33(3):555-8. PubMed ID: 2587597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Environmental novelty and illumination modify ethanol-induced open-field behavioral effects in mice.
    Fukushiro DF; Benetti LF; Josino FS; Oliveira GP; Fernandes Md; Saito LP; Uehara RA; Wuo-Silva R; Oliveira CS; Frussa-Filho R
    Pharmacol Biochem Behav; 2010 Mar; 95(1):13-22. PubMed ID: 19969017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.